Ledipasvir/Sofosbuvir for 8, 12, or 24 Weeks in Hepatitis C Patients Undergoing Dialysis for End-Stage Renal Disease.
Am J Gastroenterol
; 116(9): 1924-1928, 2021 09 01.
Article
in En
| MEDLINE
| ID: mdl-34465694
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Benzimidazoles
/
Hepatitis C
/
Fluorenes
/
Sofosbuvir
/
Kidney Failure, Chronic
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Am J Gastroenterol
Year:
2021
Document type:
Article
Affiliation country: